Cost-Outcome of Cervical Cancer Screening at Somdejphrajaotaksinmaharaj Hospital
Keywords:
Cost-Outcome, Direct Medical Cost Analysis, Cervical Cancer ScreeningAbstract
Background and Objective: The incidence of cervical cancer tends to increase and can be found more often in women of all ages. At present, there are only studies on the value of cervical cancer screening. However, the cost-outcome of cervical cancer screening has not been studied in spatial context. This study aimed to the cost-outcome of cervical cancer screening at Somdejphrajaotaksinmaharaj Hospital.
Method: This study was the descriptive study focusing on cost - outcome analysis from the service provider perspective (partially economic evaluation). Data were collected from medical records in the HosXp system of samples who were cervical cancer screen at Somdejphrajaotaksinmaharaj Hospital, fiscal year 2019 – 2021. The statistics used in the research were descriptive statistics and one-way sensitivity analysis.
Results: A total of 3,078 people were cervical cancer screening, the mean age was 41±14.68 years and the most of samples were 1,902 had marital status (61.80 %), 2,978 had eligible Universal Coverage (UC) (96.75 %), 1,711 had voluntarily participated in cervical cancer screening (55.59 %). The cervical cancer screening also revealed cell abnormalities in 92 cases (2.81 %), divided into 86 cases by conventional pap smear and 6 cases by HPV DNA Test. In addition, discovered 8 patients with cervical cancer stage I and 1 patient with cervical cancer stage II. The total cost of cervical cancer screening in 3 years was 1,094,960 baht (average 355.73 baht/person/time) and the average cost of cervical cancer screening per one case was 121,663 Baht.
Conclusions: However, cervical cancer screening was very important, if promoting screening to find new cases at the spatial level can reduce the cost of treating cervical cancer patients in the future.
References
WHO. Report of a WHO Consultation on Cervical Cancer Screening in Developing Countries [Internet]. Geneva; 2012 [cited May 15, 2022] Available from: https://apps.who.int/iris/handle/10665/42544.
Department of Disease Control. National Cancer Prevention and Control Plan in 2018 – 2022 [Internet]. Nonthaburi; 2018 [cited 2022 May 15] Available from: https://www.nci.go.th/th/File_download/แผนการป้องกันและควบคุมโรคมะเร็งแห่งชาติ.pdf.
National Cancer Institute. Cancer situation in Thailand [Internet]. Bangkok; 2013 [cited May 15, 2022] Available from: http//www.nci.go.th/cance_record/cancer_rec1.html.
Sirichaisuthikorn D. Guidelines for Cervical Cancer Screening [Internet]. Phitsanulok; 2020 [cited May 15, 2022] Available from: http://www.med.nu.ac.th/dpMed/fileKnowledge/158_2018-07-23.pdf.
The Royal Thai College of the Obstetricians and Gynecologists. Knowledge of Cervical Cancer [Internet]. Bangkok; 2020 [cited 2022 July 11] Available from: http://www.rtcog.or.th/home/ความรู้เกี่ยวกับ มะเร็ง/273/.
Data Center, Somdejphrajaotaksinmaharaj Hospital. Patient Report in 2016 – 2020. Tak: Somdejphrajao-taksinmaharaj Hospital; 2020.
Yamabhai I, Praditsitthikorn N, Anothaisintawee T, Teerawattananon Y. Economic evaluation of HPV DNA screening for cervical cancer. Nonthaburi: The Health Intervention and Technology Assessment Program; 2015.
Praditsitthikorn N. Cervical cancer screening in Thailand: A model-based economic evaluation. J Health Sys Res 2013;7(3):389-99.
Roongjangram W. Cost-Utility analysis of organized screening intervention for hepatocellular carcinoma in Thailand. Thesis in Master of Pharmaceutical Science (Community Pharmacy), Naresuan University; 2019.
The Comptroller General’s Department. Public Health Service Rates. [Internet]. Bangkok; 2022 [cited May 16, 2022] Available from: https://mbdb.cgd.go.th/wel/searchmed.jsp.
Ministry of Public Health. Public health service fee rates of service units under the Ministry of Public Health for Thai people B.E.2562. Nonthaburi: Health administration division, Ministry of Public Health.
Katanyoo K, Riewpaiboon A, Chaikledkaew U, Thavorncharoensap M. The cost of locally advanced cervical cancer in Thailand: An empirical study for economic analysis. Asian Pac J Cancer Prev 2021;22(10):3171-79.
Bank of Thailand. Exchange Rate [Internet]. Bangkok; 2022 [cited August 21, 2022] Available from: https://www.bot.or.th/App/BTWS_STAT/statistics/ReportPage.aspx?reportID=123&language=th.
Suprasert P, Manopunya M. Financial burden of gynecologic-cancer survivors associated with attendance in a surveillance program at a Tertiary Care Hospital in Thailand. Asian Pacific J Cancer Prev 2011;12(7):1761-63.
Termrungruanglert W, Havanond P, Khemapech N, Lertmaharit S, Pongpanich S, Jirakorbchaipong P, et al. Model for predicting the burden and cost of treatment in cervical cancer and HPV-related diseases in Thailand. Eur J Gynaecol Oncol 2012;33(4):391-4.
Temtanakitpaisa A. End of cervical cancer. Srinagarind Med J 2015;30(Suppl):7-9.
Supawattanabodee B, Chaowawanit W, Kittisiam T, Wiriyasirivaj B, Tangjitgamol S. Knowledge and attitudes of metropolitan women towards cervical cancer prevention with human papillomavirus vaccination: a cross-sectional study. Vajira Med J: J of Urban Med 2020;64(4):263-74.
Chaikledkaew U, Teerawattananon Y. Health technology assessment guide for Thailand, No.2, B.E.2013. Nonthaburi: The Health Intervention and Technology Assessment Program; 2013.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Srinagarind Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
